Alta Advisers’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.29M Hold
9,368
0.83% 18
2025
Q4
$1.94M Sell
9,368
-2,600
-22% -$514K 0.7% 19
2025
Q3
$2.22M Buy
11,968
+150
+1% +$25.7K 0.68% 23
2025
Q2
$1.81M Hold
11,818
0.64% 25
2025
Q1
$1.96M Buy
11,818
+3,900
+49% +$610K 0.83% 23
2024
Q4
$1.15M Buy
7,918
+818
+12% +$127K 0.72% 25
2024
Q3
$1.15M Hold
7,100
0.53% 19
2024
Q2
$1.04M Hold
7,100
0.5% 20
2024
Q1
$1.12M Hold
7,100
0.56% 19
2023
Q4
$1.11M Hold
7,100
0.59% 18
2023
Q3
$1.11M Hold
7,100
0.64% 16
2023
Q2
$1.18M Buy
7,100
+400
+6% +$64.6K 0.66% 14
2023
Q1
$1.04M Hold
6,700
0.62% 15
2022
Q4
$1.18M Hold
6,700
0.71% 11
2022
Q3
$1.09M Buy
+6,700
New +$1.13M 0.69% 12
2013
Q4
Sell
-300
Closed -$26K 62
2013
Q3
$26K Sell
300
-261
-47% -$23.4K 0.01% 65
2013
Q2
$48K Buy
+561
New +$47.6K 0.02% 56

Other funds holding JNJ

Alta Advisers's JNJ Position: Q1 2026 in Review

Alta Advisers held its Johnson & Johnson (JNJ) position steady in Q1 2026 at 9,368 shares worth $2.29M. The position accounts for 0.83% of the portfolio, ranked #18.

Alta Advisers first reported a position in JNJ in Q2 2013 and has held it in 17 quarters since. 4,614 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • Alta Advisers held 9,368 shares of Johnson & Johnson worth $2.29M as of Q1 2026.
  • Alta Advisers left its Johnson & Johnson share count unchanged in Q1 2026.
  • Johnson & Johnson made up 0.83% of Alta Advisers's portfolio in Q1 2026, its #18 holding.
  • Alta Advisers first reported a position in Johnson & Johnson in Q2 2013 and has held it in 17 quarters since.
  • 4,614 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on Alta Advisers's 13F filing for Q1 2026, filed 7 May 2026.